Country: United States
Language: English
Source: NLM (National Library of Medicine)
PROPRANOLOL HYDROCHLORIDE (UNII: F8A3652H1V) (PROPRANOLOL - UNII:9Y8NXQ24VQ)
Hikma Pharmaceuticals USA Inc.
PROPRANOLOL HYDROCHLORIDE
PROPRANOLOL HYDROCHLORIDE 20 mg in 5 mL
ORAL
PRESCRIPTION DRUG
Hypertension Propranolol hydrochloride is indicated in the management of hypertension. It may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. Propranolol is not indicated in the management of hypertensive emergencies. Angina Pectoris Due to Coronary Atherosclerosis Propranolol hydrochloride is indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. Atrial Fibrillation Propranolol hydrochloride is indicated to control ventricular rate in patients with atrial fibrillation and a rapid ventricular response. Myocardial Infarction Propranolol hydrochloride is indicated to reduce cardiovascular mortality in patients who have survived the acute phase of myocardial infarction and are clinically stable. Migraine Propranolol hydrochloride is indicated for the prophylaxis of common migraine headache. The efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and pro
Propranolol Hydrochloride Oral Solution 20 mg per 5 mL oral solution is supplied as a (strawberry-mint flavor) clear, colorless to slightly colored, viscous solution. NDC 0054-3727-63: Bottle of 500 mL 40 mg per 5 mL oral solution is supplied as a (strawberry-mint flavor) clear, colorless to slightly colored, viscous solution. NDC 0054-3730-63: Bottle of 500 mL Storage Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant, child-resistant container as defined in USP/NF. Distributed by: Hikma Pharmaceuticals USA Inc. Berkeley Heights, NJ 07922 C50000633/01 Revised September 2023
Abbreviated New Drug Application
PROPRANOLOL HYDROCHLORIDE- PROPRANOLOL HYDROCHLORIDE SOLUTION HIKMA PHARMACEUTICALS USA INC. ---------- PROPRANOLOL HYDROCHLORIDE ORAL SOLUTION RX ONLY DESCRIPTION Propranolol Hydrochloride is a synthetic beta-adrenergic receptor blocking agent chemically described as 2-Propanol, 1-[(1-methylethyl)amino]-3-(1-naphthalenyloxy)-, hydrochloride,(±)-. Its molecular and structural formula: C H NO • HCl Propranolol Hydrochloride, USP is a stable, odorless, white to off-white crystalline powder which is readily soluble in water and ethanol. Its molecular weight is 295.80. Each 5 mL of Oral Solution for oral administration contains: Alcohol……………………………………………………0.6% INACTIVE INGREDIENTS Propranolol Hydrochloride Oral Solution is available for oral administration containing either 20 mg per 5 mL or 40 mg per 5 mL of propranolol hydrochloride, USP. The oral solution contains the following inactive ingredients: citric acid anhydrous, crème de menthe flavor, disodium edetate, methyl paraben, propylene glycol, propylparaben, purified water, saccharin sodium, sorbitol solution and strawberry flavor. CLINICAL PHARMACOLOGY GENERAL Propranolol is a nonselective beta-adrenergic receptor blocking agent possessing no other autonomic nervous system activity. It specifically competes with beta-adrenergic receptor agonist agents for available receptor sites. When access to beta-receptor sites is blocked by propranolol, the chronotropic, inotropic, and vasodilator responses to 16 21 2 Propranolol Hydrochloride, USP ………………………….20 mg or 40 mg beta-adrenergic stimulation are decreased proportionately. At dosages greater than required for beta-blockade, propranolol also exerts a quinidine-like or anesthetic-like membrane action, which affects the cardiac action potential. The significance of the membrane action in the treatment of arrhythmias is uncertain. MECHANISM OF ACTION The mechanism of the antihypertensive effect of propranolol has not been established. Factors that may co Read the complete document